Cancer and IGE: Introducing the Concept of Allergooncology

ISBN-13: 9781607614500 / Angielski / Twarda / 2010 / 287 str.

Manuel L. Penichet; Erika Jensen-Jarolim

Opis

This text will include extensive epidemiological studies and preclinical results of IgE-based approaches. The editors and their collaborators believe that the role of IgE in cancer immune surveillance has been somewhat overlooked and the use of IgE-based anti-cancer approaches underexploited.

Recenzje

From the reviews:

"The book begins by giving a brief description of the long history of observations and research ... into the existence of a negative correlation between the frequency of allergies and the incidence of cancer, as well as a history of allergy research in general. ... the new concept of AllergoOncology, as introduced in this book, is a provocative one ... . a well-written and presented book introducing a new concept in cancer immunology, as well as a comprehensive description of IgE biology in general." (Andrew T. Vaughan, Immunology News, February, 2011)

"This book represents a description of how IgE antibodies may play a role protecting against cancer development and progression. ... The audience for this book includes oncologists, allergists, and researchers, as well as students and fellows. It has a place in any health sciences library. ... It is well written and full of thoughtful points and it would be a useful addition to the library of an educational institution or to the laboratory of researchers interested in this topic." (Marion C. Cohen, Doody's Review Service, July, 2010)

Spis treści

Chapter 1 Introduction Erika Jensen-Jarolim and Manuel L. Penichet Chapter 2 The Biology of IgE: Molecular Mechanism Restraining Potentially Dangerous High Serum IgE Titres in Vivo Gernot Achatz, Gertrude Achatz-Straussberger, Stefan Feichtner, Sebastian Koenigsberger, Stefan Lenz, Doris Peckl-Schmid, Nadja Zaborsky, and Marinus Lamers Chapter 3 The Biology of IgE: the Generation of High Affinity IgE Antibodies. Maria A. Curotto de Lafaille and Juan J. Lafaille Chapter 4 Epidemiological evidence: IgE, Atopy, and Solid Tumors Michelle C. Turner Chapter 5 Epidemiological Evidence: IgE, Allergies, and Hematopoietic Malignancies Otoniel Martínez-Maza, Alan Duane Moreno, and Wendy Cozen Chapter 6 Mast Cells in Allergy and Tumor Disease Anna Wasiuk, Victor C. de Vries, Elizabeth C. Nowak, and Randolph J. Noelle Chapter 7 The IgE Antibody and Its Use in Cancer Immunotherapy Tracy R. Daniels, José A. Rodríguez, Elizabeth Ortiz-Sánchez, Gustavo Helguera, and Manuel L. Penichet Chapter 8 IgE Interacts with Potent Effector Cells Against Tumors: ADCC and ADCP Sophia N. Karagiannis, Frank O. Nestle, and Hannah J. Gould Chapter 9 IgE as Adjuvant in Tumor Vaccination Elisa A. Nigro, Antonio G. Siccardi, and Luca Vangelista Chapter 10 The Targets of IgE: Allergen-Associated and Tumor-Associated Molecular Patterns (AAMPs and TAMPs) Erika Jensen-Jarolim, Diana Mechtcheriakova, Isabella Pali-Schoell Chapter 11 The Role of Th2-Mediated Anti-Tumor Immunity in Tumor Surveillance and Clearance Ljubov Simson, Julia I. Ellyard, and Christopher R. Parish

Blurb

Allergies are caused by a person’s own IgE antibodies directed against innocuous antigens like pollen or house dust mites. Interestingly, several studies have examined the relation between allergies or level of IgE and malignancies and have found an inverse association suggesting a natural role of IgE in cancer immunosurveillance. Is it thus possible that IgE immunoglobulins could have a beneficial function against cancer besides their harmful function in allergy? If so, can we exploit this beneficial function for the development of new cancer therapies? Could oncologists learn from allergists and vice versa? This book attempts to explore step by step these interesting questions, opening a novel science field: AllergoOncology.

AllergoOncology by definition aims to reveal the function of IgE-mediated immune responses against cancer cells in order to enhance the understanding of its biology and to develop novel IgE-based treatment options against malignant diseases. Cancer and IgE: Introducing the Concept of AllergoOncology opens new avenues towards IgE antibodies as key effector molecules able to confer protection against cancer development and progression. This affinity-matured class of antibody, belonging to Th2-mediated immunity, uses an exquisite panel of potent effector cells which can eradicate malignant cells. Importantly, IgE is also capable of binding to professional antigen presenting cells thereby enhancing the presentation of cancer antigens and leading to a significant anti-tumor immune response. Based on its anti-tumor efficacy, which has been shown in vitro and in preclinical models, IgE can be potentially used in human in the context passive and active cancer immunotherapy. In summary, this book, which is the first of its class, is a comprehensive volume about the evolving new field AllergoOncology.